EML6 antisense RNA 1 (EML6-AS1)

EML6 antisense RNA 1 (EML6-AS1) is a human long noncoding antisense RNA transcribed from the locus opposite the EML6 gene. As an antisense lncRNA, it may be involved in the regulation of EML6 expression through mechanisms typical to antisense RNAs, such as modulation of transcription, mRNA stability, or chromatin remodeling. However, specific biological functions, interacting proteins or RNAs, disease associations, and therapeutic relevance for EML6-AS1 are not documented in the literature or major databases as of this time. It does not appear to be a protein-coding gene, nor is it categorized as a receptor, enzyme, transporter, or canonical drug target[4]. Key context: Antisense lncRNAs in general can act as cis-regulators of adjacent gene transcription, form RNA-RNA duplexes, recruit chromatin-modifying complexes, and influence functional gene expression, but most research describing these roles relates to better-characterized antisense RNAs[1][3][5]. The lack of detailed literature about EML6-AS1 suggests it has not been implicated in major disease pathways or targeted pharmacologically to date; structured database entries exist but provide limited functional annotation[4].

Other names

EML6-AS1EML6 antisense RNA 1

Not applicable (no drugs target EML6-AS1; general mechanisms for antisense lncRNAs may include regulation of gene expression, epigenetic modification, RNA duplex formation, or recruitment of chromatin-modifying enzymes)